MEDP beats Q4 revenue by 3.3% with 32% YoY growth, but stock dips 3.6%. Valuation check needed.
AMKR beats Q4 revenue by 3% ($1.89B) & guides higher, but inventory days rise.
UPWK beats EPS/EBITDA but guides lower next qtr. Stock drops 22.7%. ARPC up 9.8%.
AI giant Anthropic faces Indian lawsuit over name rights, seeking $110K damages. Court issues notice, no injunction yet.
China has reportedly told banks to curb US Treasury exposure, framing it as concentration-risk management. The USD softened and long yields were choppy, though markets expect any reduction to be gradual, not disruptive
CINF beats Q4 revenue by 5.8% ($3.09B) & EPS by 16.6% ($3.37). BVPS up 15.2% YoY.
Brixmor (BRX) beats FFO estimates! Shares up 7% YTD, trading at $28.17. Outlook positive.
Must Read